For patients who were well-controlled on a prescription and need OTC convenience, FLONASE® Allergy Relief offers the allergy relief it had as a prescription with the benefits of a branded OTC1-13

Same prescription strength, 24-hour relief

The #1-prescribed INS ingredient* for allergic rhinitis is available OTC—delivers the same trusted, prescription-strength relief1-14

Relieves the symptoms of seasonal and perennial
allergic rhinitis15

In addition to treating congestion, runny nose, sneezing, and itchy nose, FLONASE® Allergy Relief is the first OTC INS indicated to relieve itchy, watery eyes1-13

Recommended first-line, long-term

INSs such as FLONASE® Allergy Relief are recommended for initial and maintenance treatment of nasal allergies


First-line nasal allergy treatment: Allergic Rhinitis and its Impact on Asthma (ARIA) treatment guidelines, issued in partnership with the World Health Organization, recommend INS treatments like FLONASE® as first-line treatment for allergic rhinitis, calling them “the most effective drugs”2,16,17 

Long-term nasal allergy treatment: INS treatments are recognized as the most effective, long-term treatment option for allergic rhinitis†2,16,17

The Efficacy of Prescription Fluticasone Propionate
Delivered With the Benefits of an OTC

  • Availability: 750,000 retail outlets across the country sell OTC products18
  • Convenience: 93% of adults prefer to treat minor ailments with OTC medicines and 85% of parents prefer to treat their children’s minor ailments with an OTC medicine before seeking professional care18 
  • Independence: 70% to 90% of all illness episodes are addressed with self-treatment18

Prescription-Strength Fluticasone Propionate Available

Help your allergy patients make the transition to OTC
FLONASE® Allergy Relief

  • Easily accessible and convenient
  • No prescription hassles
  • Additional support, coupons, and educational materials for patients
  • Available in 60- and 120-metered spray bottles
  • Indicated to relieve itchy, watery eyes15

FLONASE® Allergy Relief
Drug Facts15

Active ingredient: fluticasone propionate

Uses: Temporarily relieves nasal congestion, runny nose, sneezing, itchy nose, and itchy, watery eyes


FLONASE® Allergy
Relief Clinical Profile

Learn more about the FLONASE® Allergy Relief clinical profile, including efficacy, patient preference, safety, and more.



Patient education materials and more


Explore different patient types and find out which product is right for your patients


Learn more about FLONASE® Allergy Relief Administration and Dosing


1. Greiner, A. N., Hellings, P. W., Rotiroti, G., and Scadding, G. K. Allergic Rhinitis. The Lancet. 378(9809): 2112-2122, 2011. 2. Wallace, D. V., Dykewicz, M. S., Bernstein, D. I., Blessing-Moore, J. et al. The Diagnosis and Management of Rhinitis: An Updated Practice Parameter. Journal of Allergy and Clinical Immunology. 122(2 SUPPL.): S1-S84, 2008. 3. Nathan, R. A., Bronsky, E. A., Fireman, P., Grossman, J. et al. Once Daily Fluticasone Propionate Aqueous Nasal Spray Is an Effective Treatment for Seasonal Allergic Rhinitis. Annals of Allergy. 67(3): 332-338, 1991. 4. Banov, C. H., Woehler, T. R., LaForce, C. F., Pearlman, D. S. et al. Once Daily Intranasal Fluticasone Propionate Is Effective for Perennial Allergic Rhinitis. Annals of Allergy. 73(3): 240-246, 1994. 5. Dykewicz, M. S., Kaiser, H. B., Nathan, R. A., Goode-Sellers, S. et al. Fluticasone Propionate Aqueous Nasal Spray Improves Nasal Symptoms of Seasonal Allergic Rhinitis When Used As Needed (Prn). Annals of Allergy, Asthma and Immunology. 91(1): 44-48, 2003. 6. Scadding, G. K., Lund, V. J., Jacques, L. A., and Richards, D. H. A Placebo-Controlled Study of Fluticasone Propionate Aqueous Nasal Spray and Beclomethasone Dipropionate in Perennial Rhinitis: Efficacy in Allergic and Non-Allergic Perennial Rhinitis. Clinical and Experimental Allergy. 25(8): 737-743, 1995. 7. Van As, A., Bronsky, E. A., Dockhorn, R. J., Grossman, J. et al. Once Daily Fluticasone Propionate Is As Effective for Perennial Allergic Rhinitis As Twice Daily Beclomethasone Diproprionate. Journal of Allergy and Clinical Immunology. 91(6): 1146-1154, 1993. 8. Data on file, GlaxoSmithKline. GSK: Result Summary for Study FNM40184. Http://Www.Gsk-Clinicalstudyregister.Com/. 12-19-2005. 9. Ratner, P. H., Howland III, W. C., Jacobs, R. L., Reed, K. D. et al. Relief of Sinus Pain and Pressure With Fluticasone Propionate Aqueous Nasal Spray: A Placebo-Controlled Trial in Patients With Allergic Rhinitis. Allergy and Asthma Proceedings. 23(4): 259-263, 2002. 10. Haye, R. and Gomez, E. G. A Multicentre Study to Assess Long-Term Use of Fluticasone Propionate Aqueous Nasal Spray in Comparison With Beclomethasone Dipropionate Aqueous Nasal Spray in the Treatment of Perennial Rhinitis. Rhinology. 31(4): 169-174, 1993. 11. Bernstein, D. I., Levy, A. L., Hampel, F. C., Baidoo, C. A. et al. Treatment With Intranasal Fluticasone Propionate Significantly Improves Ocular Symptoms in Patients With Seasonal Allergic Rhinitis. Clinical and Experimental Allergy. 34(6): 952-957, 2004. 12. DeWester, J., Philpot, E. E., Westlund, R. E., Cook, C. K. et al. The Efficacy of Intranasal Fluticasone Propionate in the Relief of Ocular Symptoms Associated With Seasonal Allergic Rhinitis. Allergy and Asthma Proceedings. 24(5): 331-337, 2003. 13. Data on file, GlaxoSmithKline. GSK: Result Summary for Study FNM30034. Http://Www.Gsk-Clinicalstudyregister.Com/. 5-12-2005. 14. IMS Health Incorporated. IMS National Prescription Audit MAT (DATES TO COME) 15. FLONASE® Drug Facts Label. 16. Bousquet, J., Khaltaev, N., Cruz, A. A., Denburg, J. et al. Allergic Rhinitis and Its Impact on Asthma (ARIA) 2008 Update (in Collaboration With the World Health Organization, GA2LEN and AllerGen). Allergy: European Journal of Allergy and Clinical Immunology. 63(SUPPL. 86): 8-160, 2008. 17. Derendorf H, Meltzer EO. Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications. Allergy. 2008;63(10):1292-1300. 18. Statistics on OTC Use. Consumer Healthcare Products Association Website. http://www.chpa.org/marketstats.aspx. Accessed August 22, 2016.